{
  "DOI": "10.1186/s40246-018-0186-y",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-018-0186-y",
  "alternative-id": [
    "186"
  ],
  "article-number": "4",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "17 October 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "5 December 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "10 January 2019"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "This study was approved by the Ethics Committee of Nanjing Drum Tower Hospital, and all procedures performed within this study were done in accordance with the Chinese ethical standards and with the 2008 Helsinki declaration. Informed written consent of participation was obtained from each human participant."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "All participants have consented to share their de-identified information."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    },
    {
      "group": {
        "label": "Publisher’s Note",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Yi",
      "given": "Dandan",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Lei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Luo",
      "given": "Jiaqi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "You",
      "given": "Xiaobin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Tao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zi",
      "given": "Yi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Xiaoting",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Ru",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhong",
      "given": "Zaixuan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tang",
      "given": "Xiaoqiao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Ang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Shi",
      "given": "Yujian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rao",
      "given": "Jianmei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Yifen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sang",
      "given": "Jianfeng",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        1,
        10
      ]
    ],
    "date-time": "2019-01-10T09:28:44Z",
    "timestamp": 1547112524000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        1,
        10
      ]
    ],
    "date-time": "2020-01-10T00:11:19Z",
    "timestamp": 1578615079000
  },
  "funder": [
    {
      "award": [
        "YKK15082"
      ],
      "name": "Nanjing Medical Science and Technology Development Project"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        13
      ]
    ],
    "date-time": "2023-11-13T05:22:28Z",
    "timestamp": 1699852948727
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        1,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            1,
            10
          ]
        ],
        "date-time": "2019-01-10T00:00:00Z",
        "timestamp": 1547078400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0186-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-018-0186-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0186-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2019,
        1,
        10
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        1,
        10
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s12943-018-0850-9",
      "doi-asserted-by": "publisher",
      "key": "186_CR1",
      "unstructured": "Shi Y, Jin J, Ji W, Guan X. Therapeutic landscape in mutational triple negative breast cancer. Mol Cancer. 2018;17(99). \n                    https://doi.org/10.1186/s12943-018-0850-9\n                    \n                  ."
    },
    {
      "DOI": "10.1172/JCI45014.2750",
      "author": "BD Lehmann",
      "doi-asserted-by": "publisher",
      "first-page": "2750",
      "journal-title": "J Clin Invest",
      "key": "186_CR2",
      "unstructured": "Lehmann BD, Shyr Y, Pietenpol JA, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121:2750–67. \n                    https://doi.org/10.1172/JCI45014.2750\n                    \n                  .",
      "volume": "121",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature11412",
      "author": "The Cancer Genome Atlas",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "Nature",
      "key": "186_CR3",
      "unstructured": "The Cancer Genome Atlas. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70. \n                    https://doi.org/10.1038/nature11412\n                    \n                  .",
      "volume": "490",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature10933",
      "author": "SP Shah",
      "doi-asserted-by": "publisher",
      "first-page": "395",
      "journal-title": "Nature",
      "key": "186_CR4",
      "unstructured": "Shah SP, Roth A, Goya R, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486:395–9. \n                    https://doi.org/10.1038/nature10933\n                    \n                  .",
      "volume": "486",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2014.57.1414",
      "author": "FJ Couch",
      "doi-asserted-by": "publisher",
      "first-page": "304",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "186_CR5",
      "unstructured": "Couch FJ, Hart SN, Sharma P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33(4):304–11. \n                    https://doi.org/10.1200/JCO.2014.57.1414\n                    \n                  .",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1093/annonc/mdy024",
      "author": "Y Bareche",
      "doi-asserted-by": "publisher",
      "first-page": "895",
      "journal-title": "Ann Oncol",
      "key": "186_CR6",
      "unstructured": "Bareche Y, Venet D, Ignatiadis M, et al. Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis. Ann Oncol. 2018;29:895–902. \n                    https://doi.org/10.1093/annonc/mdy024\n                    \n                  .",
      "volume": "29",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nrclinonc.2016.66",
      "author": "G Bianchini",
      "doi-asserted-by": "publisher",
      "first-page": "674",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "186_CR7",
      "unstructured": "Bianchini G, Balko JM, Mayer IA, Sanders ME. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674–90. \n                    https://doi.org/10.1038/nrclinonc.2016.66\n                    \n                  .",
      "volume": "13",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13058-015-0627-7",
      "doi-asserted-by": "publisher",
      "key": "186_CR8",
      "unstructured": "Thompson ER, Gorringe KL, Rowley SM, et al. Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls. Breast Cancer Res. 2015;17(111). \n                    https://doi.org/10.1186/s13058-015-0627-7\n                    \n                  ."
    },
    {
      "DOI": "10.1073/pnas.1407909111",
      "doi-asserted-by": "publisher",
      "key": "186_CR9",
      "unstructured": "Kiiski JI, Pelttari LM, Khan S, et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc Natl Acad Sci USA. 2014;111(42):15172-7. \n                    https://doi.org/10.1073/pnas.1407909111\n                    \n                  ."
    },
    {
      "DOI": "10.1158/1078-0432.CCR-16-3227",
      "author": "J Sun",
      "doi-asserted-by": "publisher",
      "first-page": "6113",
      "journal-title": "Clin Cancer Res",
      "key": "186_CR10",
      "unstructured": "Sun J, Meng H, Yao L, et al. Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res. 2017;23:6113–9. \n                    https://doi.org/10.1158/1078-0432.CCR-16-3227\n                    \n                  .",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1159/000455999",
      "author": "RK Schmutzler",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Breast Care",
      "key": "186_CR11",
      "unstructured": "Schmutzler RK. Germline mutations in triple-negative breast cancer. Breast Care. 2017;12:15–9. \n                    https://doi.org/10.1159/000455999\n                    \n                  .",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.5732/cjc.011.10106",
      "author": "W Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "287",
      "journal-title": "Chin J Cancer",
      "key": "186_CR12",
      "unstructured": "Zhou W, Christiani DC. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer. 2011;30:287–92. \n                    https://doi.org/10.5732/cjc.011.10106\n                    \n                  .",
      "volume": "30",
      "year": "2011"
    },
    {
      "DOI": "10.1101/274100",
      "doi-asserted-by": "publisher",
      "key": "186_CR13",
      "unstructured": "Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. bioRxiv. 2018:274100. \n                    https://doi.org/10.1101/274100\n                    \n                  ."
    },
    {
      "DOI": "10.1093/bioinformatics/btp324",
      "author": "H Li",
      "doi-asserted-by": "publisher",
      "first-page": "1754",
      "journal-title": "Bioinformatics",
      "key": "186_CR14",
      "unstructured": "Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60. \n                    https://doi.org/10.1093/bioinformatics/btp324\n                    \n                  .",
      "volume": "25",
      "year": "2009"
    },
    {
      "DOI": "10.1101/gr.107524.110",
      "author": "A McKenna",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "journal-title": "Genome Res",
      "key": "186_CR15",
      "unstructured": "McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303. \n                    https://doi.org/10.1101/gr.107524.110\n                    \n                  .",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s42003-018-0023-9",
      "author": "G Narzisi",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Commun Biol",
      "key": "186_CR16",
      "unstructured": "Narzisi G, Corvelo A, Arora K, et al. Genome-wide somatic variant calling using localized colored de Bruijn graphs. Commun Biol. 2018;1:20. \n                    https://doi.org/10.1038/s42003-018-0023-9\n                    \n                  .",
      "volume": "1",
      "year": "2018"
    },
    {
      "DOI": "10.1093/bioinformatics/btq330",
      "author": "W McLaren",
      "doi-asserted-by": "publisher",
      "first-page": "2069",
      "journal-title": "Bioinformatics",
      "key": "186_CR17",
      "unstructured": "McLaren W, Pritchard B, Rios D, et al. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. Bioinformatics. 2010;26:2069–70. \n                    https://doi.org/10.1093/bioinformatics/btq330\n                    \n                  .",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1093/nar/gkq603",
      "author": "K Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e164",
      "journal-title": "Nucleic Acids Res",
      "key": "186_CR18",
      "unstructured": "Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. \n                    https://doi.org/10.1093/nar/gkq603\n                    \n                  .",
      "volume": "38",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nbt.1754",
      "author": "JT Robinson",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "journal-title": "Nat Biotechnol",
      "key": "186_CR19",
      "unstructured": "Robinson JT, Thorvaldsdóttir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6. \n                    https://doi.org/10.1038/nbt.1754\n                    \n                  .",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "186_CR20",
      "unstructured": "Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–23. \n                    https://doi.org/10.1038/gim.2015.30\n                    \n                  .",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature12213",
      "author": "MS Lawrence",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "journal-title": "Nature",
      "key": "186_CR21",
      "unstructured": "Lawrence MS, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2014;499:214–8. \n                    https://doi.org/10.1038/nature12213\n                    \n                  .",
      "volume": "499",
      "year": "2014"
    },
    {
      "DOI": "10.1101/gr.120477.111",
      "author": "F Vandin",
      "doi-asserted-by": "publisher",
      "first-page": "375",
      "journal-title": "Genome Res",
      "key": "186_CR22",
      "unstructured": "Vandin F, Upfal E, Raphael BJ. De novo discovery of mutated driver pathways in cancer. Genome Res. 2012;22:375–85. \n                    https://doi.org/10.1101/gr.120477.111\n                    \n                  .",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1177/1947601911413466",
      "author": "D Malkin",
      "doi-asserted-by": "publisher",
      "first-page": "475",
      "journal-title": "Genes Cancer",
      "key": "186_CR23",
      "unstructured": "Malkin D. Li-Fraumeni syndrome. Genes Cancer. 2011;2:475–84. \n                    https://doi.org/10.1177/1947601911413466\n                    \n                  .",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1002/cncr.30498",
      "author": "SS Buys",
      "doi-asserted-by": "publisher",
      "first-page": "1721",
      "journal-title": "Cancer",
      "key": "186_CR24",
      "unstructured": "Buys SS, Sandbach JF, Gammon A, et al. A study of over 35, 000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721–30. \n                    https://doi.org/10.1002/cncr.30498\n                    \n                  .",
      "volume": "123",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2017.254",
      "doi-asserted-by": "publisher",
      "key": "186_CR25",
      "unstructured": "Roberts ME, Jackson SA, Susswein LR, et al. MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genet Med. 2018. \n                    https://doi.org/10.1038/gim.2017.254\n                    \n                  ."
    },
    {
      "DOI": "10.1038/modpathol.2016.39",
      "author": "PS Weisman",
      "doi-asserted-by": "publisher",
      "first-page": "476",
      "journal-title": "Mod Pathol",
      "key": "186_CR26",
      "unstructured": "Weisman PS, Ng CKY, Brogi E, et al. Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Mod Pathol. 2016;29:476–88. \n                    https://doi.org/10.1038/modpathol.2016.39\n                    \n                  .",
      "volume": "29",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.bbcan.2018.05.004",
      "doi-asserted-by": "publisher",
      "key": "186_CR27",
      "unstructured": "Shi Y, Yang F, Huang D, Guan X. Androgen blockade based clinical trials landscape in triple negative breast cancer. Biochim Biophys Acta Rev Cancer. 2018. \n                    https://doi.org/10.1016/j.bbcan.2018.05.004\n                    \n                  ."
    },
    {
      "DOI": "10.1016/j.ejca.2017.07.026",
      "author": "L Nebot-bral",
      "doi-asserted-by": "publisher",
      "first-page": "290",
      "journal-title": "Eur J Cancer",
      "key": "186_CR28",
      "unstructured": "Nebot-bral L, Brandao D, Verlingue L. Hypermutated tumours in the era of immunotherapy: the paradigm of personalised medicine. Eur J Cancer. 2017;84:290–303. \n                    https://doi.org/10.1016/j.ejca.2017.07.026\n                    \n                  .",
      "volume": "84",
      "year": "2017"
    },
    {
      "author": "I Dua",
      "first-page": "20",
      "journal-title": "Am J Hum Oncol",
      "key": "186_CR29",
      "unstructured": "Dua I, Tan AR. Immunotherapy for triple-negative breast cancer: a focus on immune checkpoint inhibitors. Am J Hum Oncol. 2017;13:20–7 \n                    https://www.gotoper.com/publications/ajho/2017/2017may/immunotherapy-for-triple-negative-breast-cancer-a-focus-on-immuno-checkpoint-inhibitors\n                    \n                  .",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ctrv.2016.12.010",
      "doi-asserted-by": "publisher",
      "key": "186_CR30",
      "unstructured": "Treatment A, Costa R, Shah AN, et al. Targeting epidermal growth factor receptor in triple negative breast cancer. Cancer Treat Rev. 2016. \n                    https://doi.org/10.1016/j.ctrv.2016.12.010\n                    \n                  ."
    }
  ],
  "reference-count": 30,
  "references-count": 30,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-018-0186-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}